{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:31:13Z","timestamp":1772829073354,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"20","license":[{"start":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T00:00:00Z","timestamp":1396569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s00213-014-3530-5","type":"journal-article","created":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T06:40:30Z","timestamp":1396507230000},"page":"3973-3985","source":"Crossref","is-referenced-by-count":33,"title":["Piromelatine exerts antinociceptive effect via melatonin, opioid, and 5HT1A receptors and hypnotic effect via melatonin receptors in a mouse model of neuropathic pain"],"prefix":"10.1007","volume":"231","author":[{"given":"Yuan-Yuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dou","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Min","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Laudon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neng-Neng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Urade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,4]]},"reference":[{"key":"3530_CR1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.pain.2007.01.025","volume":"132","author":"M Ambriz-Tututi","year":"2007","unstructured":"Ambriz-Tututi M, Granados-Soto V (2007) Oral and spinal melatonin reduces tactile allodynia in rats via activation of MT2 and opioid receptors. Pain 132:273\u2013280","journal-title":"Pain"},{"key":"3530_CR2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2006.03.067","volume":"538","author":"M Anjaneyulu","year":"2006","unstructured":"Anjaneyulu M, Chopra K (2006) Possible involvement of cholinergic and opioid receptor mechanisms in fluoxetine mediated antinociception response in streptozotocin-induced diabetic mice. Eur J Pharmacol 538:80\u201384","journal-title":"Eur J Pharmacol"},{"key":"3530_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.ajp.0000210945.27052.b3","volume":"23","author":"CE Argoff","year":"2007","unstructured":"Argoff CE (2007) The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach. Clin J Pain 23:15\u201322","journal-title":"Clin J Pain"},{"key":"3530_CR4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1211\/jpp.62.02.0008","volume":"62","author":"TA Barros","year":"2010","unstructured":"Barros TA, de Freitas LA, Filho JM, Nunes XP, Giulietti AM, de Souza GE, dos Santos RR, Soares MB, Villarreal CF (2010) Antinociceptive and anti-inflammatory properties of 7-hydroxycoumarin in experimental animal models: potential therapeutic for the control of inflammatory chronic pain. J Pharm Pharmacol 62:205\u2013213","journal-title":"J Pharm Pharmacol"},{"key":"3530_CR5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/AJP.0b013e3182313899","volume":"28","author":"T Blagestad","year":"2012","unstructured":"Blagestad T, Pallesen S, Lunde LH, Sivertsen B, Nordhus IH, Gronli J (2012) Sleep in older chronic pain patients: a comparative polysomnographic study. Clin J Pain 28:277\u2013283","journal-title":"Clin J Pain"},{"key":"3530_CR6","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.bjp.0703130","volume":"129","author":"C Browning","year":"2000","unstructured":"Browning C, Beresford I, Fraser N, Giles H (2000) Pharmacological characterization of human recombinant melatonin mt(1) and MT(2) receptors. Br J Pharmacol 129:877\u2013886","journal-title":"Br J Pharmacol"},{"key":"3530_CR7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.smrv.2004.06.004","volume":"9","author":"A Brzezinski","year":"2005","unstructured":"Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben-Shushan A, Ford I (2005) Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev 9:41\u201350","journal-title":"Sleep Med Rev"},{"key":"3530_CR8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbr.2013.01.008","volume":"243","author":"S Comai","year":"2013","unstructured":"Comai S, Ochoa-Sanchez R, Gobbi G (2013) Sleep-wake characterization of double MT(1)\/MT(2) receptor knockout mice and comparison with MT(1) and MT(2) receptor knockout mice. Behav Brain Res 243:231\u2013238","journal-title":"Behav Brain Res"},{"key":"3530_CR9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","volume":"20","author":"WJ Dixon","year":"1980","unstructured":"Dixon WJ (1980) Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20:441\u2013462","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3530_CR10","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1096\/fasebj.12.12.1211","volume":"12","author":"ML Dubocovich","year":"1998","unstructured":"Dubocovich ML, Yun K, Al-Ghoul WM, Benloucif S, Masana MI (1998) Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J 12:1211\u20131220","journal-title":"FASEB J"},{"key":"3530_CR11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-079X.2005.00230.x","volume":"39","author":"ML Dubocovich","year":"2005","unstructured":"Dubocovich ML, Hudson RL, Sumaya IC, Masana MI, Manna E (2005) Effect of MT1 melatonin receptor deletion on melatonin-mediated phase shift of circadian rhythms in the C57BL\/6 mouse. J Pineal Res 39:113\u2013120","journal-title":"J Pineal Res"},{"key":"3530_CR12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-079X.2008.00565.x","volume":"45","author":"SP Fisher","year":"2008","unstructured":"Fisher SP, Davidson K, Kulla A, Sugden D (2008) Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat. J Pineal Res 45:125\u2013132","journal-title":"J Pineal Res"},{"key":"3530_CR13","volume-title":"The mouse brain in stereotaxic coordinates","author":"KBJ Franklin","year":"1997","unstructured":"Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic, San Diego"},{"key":"3530_CR14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-079X.2009.00683.x","volume":"47","author":"A Gomez-Corvera","year":"2009","unstructured":"Gomez-Corvera A, Cerrillo I, Molinero P, Naranjo MC, Lardone PJ, Sanchez-Hidalgo M, Carrascosa-Salmoral MP, Medrano-Campillo P, Guerrero JM, Rubio A (2009) Evidence of immune system melatonin production by two pineal melatonin deficient mice, C57BL\/6 and Swiss strains. J Pineal Res 47:15\u201322","journal-title":"J Pineal Res"},{"key":"3530_CR15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","volume":"32","author":"K Hargreaves","year":"1988","unstructured":"Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77\u201388","journal-title":"Pain"},{"key":"3530_CR16","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1073\/pnas.0600451103","volume":"103","author":"ZL Huang","year":"2006","unstructured":"Huang ZL, Mochizuki T, Qu WM, Hong ZY, Watanabe T, Urade Y, Hayaishi O (2006) Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice. Proc Natl Acad Sci U S A 103:4687\u20134692","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3530_CR17","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1128\/MCB.23.3.1054-1060.2003","volume":"23","author":"X Jin","year":"2003","unstructured":"Jin X, von Gall C, Pieschl RL, Gribkoff VK, Stehle JH, Reppert SM, Weaver DR (2003) Targeted disruption of the mouse Mel(1b) melatonin receptor. Mol Cell Biol 23:1054\u20131060","journal-title":"Mol Cell Biol"},{"key":"3530_CR18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuropharm.2004.09.007","volume":"48","author":"K Kato","year":"2005","unstructured":"Kato K, Hirai K, Nishiyama K, Uchikawa O, Fukatsu K, Ohkawa S, Kawamata Y, Hinuma S, Miyamoto M (2005) Neurochemical properties of ramelteon (TAK-375), a selective MT1\/MT2 receptor agonist. Neuropharmacology 48:301\u2013310","journal-title":"Neuropharmacology"},{"key":"3530_CR19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1254\/jjp.27.117","volume":"27","author":"H Kuribara","year":"1977","unstructured":"Kuribara H, Higuchi Y, Tadokoro S (1977) Effects of central depressants on rota-rod and traction performances in mice. Jpn J Pharmacol 27:117\u2013126","journal-title":"Jpn J Pharmacol"},{"key":"3530_CR20","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1016\/0024-3205(81)90710-4","volume":"29","author":"ML Lakin","year":"1981","unstructured":"Lakin ML, Miller CH, Stott ML, Winters WD (1981) Involvement of the pineal gland and melatonin in murine analgesia. Life Sci 29:2543\u20132551","journal-title":"Life Sci"},{"key":"3530_CR21","unstructured":"Laudon M, Peleg-Shulman T (2009) Pyrone-indole derivatives and process for their preparation. Patent US 7635710 B2"},{"key":"3530_CR22","doi-asserted-by":"crossref","first-page":"A34","DOI":"10.1093\/sleep\/31.1.34","volume":"31","author":"M Laudon","year":"2008","unstructured":"Laudon M, Urade Y, Huang Z (2008) Neu-P11, a novel melatonin agonist: effects on sleep and EEG power spectra in rats. Sleep 31:A34","journal-title":"Sleep"},{"key":"3530_CR23","first-page":"A655","volume":"35","author":"M Laudon","year":"2012","unstructured":"Laudon M, Katz A, Metzger D, Staner L, Pross N, Cornette F, Guichard N, Nir T, Zisapel N (2012) Tolerability, pharmacokinetic and pharmacodynamic evaluation of multiple ascending doses of Neu-P11 in insomnia patients. Sleep 35:A655","journal-title":"Sleep"},{"key":"3530_CR24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0896-6273(00)80350-5","volume":"19","author":"C Liu","year":"1997","unstructured":"Liu C, Weaver DR, Jin X, Shearman LP, Pieschl RL, Gribkoff VK, Reppert SM (1997) Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 19:91\u2013102","journal-title":"Neuron"},{"key":"3530_CR25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1600-079X.2006.00380.x","volume":"41","author":"M Mantovani","year":"2006","unstructured":"Mantovani M, Kaster MP, Pertile R, Calixto JB, Rodrigues AL, Santos AR (2006) Mechanisms involved in the antinociception caused by melatonin in mice. J Pineal Res 41:382\u2013389","journal-title":"J Pineal Res"},{"key":"3530_CR26","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0024-3205(02)01991-4","volume":"71","author":"WB Mendelson","year":"2002","unstructured":"Mendelson WB (2002) Melatonin microinjection into the medial preoptic area increases sleep in the rat. Life Sci 71:2067\u20132070","journal-title":"Life Sci"},{"key":"3530_CR27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.pain.2010.03.030","volume":"149","author":"A Mickle","year":"2010","unstructured":"Mickle A, Sood M, Zhang Z, Shahmohammadi G, Sengupta JN, Miranda A (2010) Antinociceptive effects of melatonin in a rat model of post-inflammatory visceral hyperalgesia: a centrally mediated process. Pain 149:555\u2013564","journal-title":"Pain"},{"key":"3530_CR28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1755-5949.2008.00066.x","volume":"15","author":"M Miyamoto","year":"2009","unstructured":"Miyamoto M (2009) Pharmacology of ramelteon, a selective MT1\/MT2 receptor agonist: a novel therapeutic drug for sleep disorders. CNS Neurosci Ther 15:32\u201351","journal-title":"CNS Neurosci Ther"},{"key":"3530_CR29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1046\/j.0007-1331.2001.00761.x","volume":"14","author":"FP Monnet","year":"2002","unstructured":"Monnet FP (2002) Melatonin modulates [3h]serotonin release in the rat hippocampus: effects of circadian rhythm. J Neuroendocrinol 14:194\u2013199","journal-title":"J Neuroendocrinol"},{"key":"3530_CR30","first-page":"S230","volume":"12","author":"AK Morin","year":"2006","unstructured":"Morin AK (2006) Strategies for treating chronic insomnia. Am J Manage Care 12:S230\u2013S245","journal-title":"Am J Manage Care"},{"key":"3530_CR31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00002508-199812000-00007","volume":"14","author":"CM Morin","year":"1998","unstructured":"Morin CM, Gibson D, Wade J (1998) Self-reported sleep and mood disturbance in chronic pain patients. Clin J Pain 14:311\u2013314","journal-title":"Clin J Pain"},{"key":"3530_CR32","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.pain.2011.02.016","volume":"152","author":"M Narita","year":"2011","unstructured":"Narita M, Niikura K, Nanjo-Niikura K, Furuya M, Yamashita A, Saeki M, Matsushima Y, Imai S, Shimizu T, Asato M, Kuzumaki N, Okutsu D, Miyoshi K, Suzuki M, Tsukiyama Y, Konno M, Yomiya K, Matoba M, Suzuki T (2011) Sleep disturbances in a neuropathic pain-like condition in the mouse are associated with altered GABAergic transmission in the cingulate cortex. Pain 152:1358\u20131372","journal-title":"Pain"},{"key":"3530_CR33","doi-asserted-by":"crossref","first-page":"18439","DOI":"10.1523\/JNEUROSCI.2676-11.2011","volume":"31","author":"R Ochoa-Sanchez","year":"2011","unstructured":"Ochoa-Sanchez R, Comai S, Lacoste B, Bambico FR, Dominguez-Lopez S, Spadoni G, Rivara S, Bedini A, Angeloni D, Fraschini F, Mor M, Tarzia G, Descarries L, Gobbi G (2011) Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand. J Neurosci 31:18439\u201318452","journal-title":"J Neurosci"},{"key":"3530_CR34","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1517\/13543784.2012.714771","volume":"21","author":"L Paulis","year":"2012","unstructured":"Paulis L, Simko F, Laudon M (2012) Cardiovascular effects of melatonin receptor agonists. Expert Opin Investig Drugs 21:1661\u20131678","journal-title":"Expert Opin Investig Drugs"},{"key":"3530_CR35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.euroneuro.2009.04.001","volume":"19","author":"E Peles","year":"2009","unstructured":"Peles E, Schreiber S, Adelson M (2009) Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose. Eur Neuropsychopharmacol 19:581\u2013588","journal-title":"Eur Neuropsychopharmacol"},{"key":"3530_CR36","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pain.2004.03.039","volume":"110","author":"L Perissin","year":"2004","unstructured":"Perissin L, Boccalon S, Scaggiante B, Petrelli L, Ortolani F, Porro CA (2004) Diurnal changes of tonic nociceptive responses in mice: evidence for a proalgesic role of melatonin. Pain 110:250\u2013258","journal-title":"Pain"},{"key":"3530_CR37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.brainresbull.2004.09.008","volume":"64","author":"S Shavali","year":"2005","unstructured":"Shavali S, Ho B, Govitrapong P, Sawlom S, Ajjimaporn A, Klongpanichapak S, Ebadi M (2005) Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid. Brain Res Bull 64:471\u2013479","journal-title":"Brain Res Bull"},{"key":"3530_CR38","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0014-2999(90)90328-4","volume":"180","author":"JA Siuciak","year":"1990","unstructured":"Siuciak JA, Fang JM, Dubocovich ML (1990) Autoradiographic localization of 2-[125I]iodomelatonin binding sites in the brains of C3H\/HeN and C57BL\/6J strains of mice. Eur J Pharmacol 180:387\u2013390","journal-title":"Eur J Pharmacol"},{"key":"3530_CR39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1087-0792(03)00044-3","volume":"8","author":"MT Smith","year":"2004","unstructured":"Smith MT, Haythornthwaite JA (2004) How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev 8:119\u2013132","journal-title":"Sleep Med Rev"},{"key":"3530_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1005444719169","volume":"23","author":"MT Smith","year":"2000","unstructured":"Smith MT, Perlis ML, Smith MS, Giles DE, Carmody TP (2000) Sleep quality and presleep arousal in chronic pain. J Behav Med 23:1\u201313","journal-title":"J Behav Med"},{"key":"3530_CR41","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1755-5949.2010.00197.x","volume":"17","author":"G Spadoni","year":"2011","unstructured":"Spadoni G, Bedini A, Rivara S, Mor M (2011) Melatonin receptor agonists: new options for insomnia and depression treatment. CNS Neurosci Ther 17:733\u2013741","journal-title":"CNS Neurosci Ther"},{"key":"3530_CR42","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.pnpbp.2011.03.013","volume":"35","author":"V Srinivasan","year":"2011","unstructured":"Srinivasan V, Brzezinski A, Pandi-Perumal SR, Spence DW, Cardinali DP, Brown GM (2011) Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics? Prog Neuropsychopharmacol Biol Psychiatry 35:913\u2013923","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3530_CR43","doi-asserted-by":"crossref","unstructured":"Takemura Y, Yamashita A, Horiuchi H, Furuya M, Yanase M, Niikura K, Imai S, Hatakeyama N, Kinoshita H, Tsukiyama Y, Senba E, Matoba M, Kuzumaki N, Yamazaki M, Suzuki T, Narita M (2011) Effects of gabapentin on brain hyperactivity related to pain and sleep disturbance under a neuropathic pain-like state using fMRI and brain wave analysis. Synapse 65:668\u2013676","DOI":"10.1002\/syn.20898"},{"key":"3530_CR44","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/aps.2010.80","volume":"31","author":"SW Tian","year":"2010","unstructured":"Tian SW, Laudon M, Han L, Gao J, Huang FL, Yang YF, Deng HF (2010) Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models. Acta Pharmacol Sin 31:775\u2013783","journal-title":"Acta Pharmacol Sin"},{"key":"3530_CR45","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.lfs.2005.07.002","volume":"78","author":"A Ulugol","year":"2006","unstructured":"Ulugol A, Dokmeci D, Guray G, Sapolyo N, Ozyigit F, Tamer M (2006) Antihyperalgesic, but not antiallodynic, effect of melatonin in nerve-injured neuropathic mice: Possible involvements of the L-arginine-NO pathway and opioid system. Life Sci 78:1592\u20131597","journal-title":"Life Sci"},{"key":"3530_CR46","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1211\/0022357021729","volume":"55","author":"F Wang","year":"2003","unstructured":"Wang F, Li JC, Wu CF, Yang JY, Zhang RM, Chai HF (2003) Influences of a light\u2013dark profile and the pineal gland on the hypnotic activity of melatonin in mice and rats. J Pharm Pharmacol 55:1307\u20131312","journal-title":"J Pharm Pharmacol"},{"key":"3530_CR47","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/j.pain.2012.08.016","volume":"153","author":"S Wang","year":"2012","unstructured":"Wang S, Tian Y, Song L, Lim G, Tan Y, You Z, Chen L, Mao J (2012) Exacerbated mechanical hyperalgesia in rats with genetically predisposed depressive behavior: role of melatonin and NMDA receptors. Pain 153:2448\u20132457","journal-title":"Pain"},{"key":"3530_CR48","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1600-079X.2011.00895.x","volume":"51","author":"M Wilhelmsen","year":"2011","unstructured":"Wilhelmsen M, Amirian I, Reiter RJ, Rosenberg J, Gogenur I (2011) Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies. J Pineal Res 51:270\u2013277","journal-title":"J Pineal Res"},{"key":"3530_CR49","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/sleep\/29.5.609","volume":"29","author":"JK Wyatt","year":"2006","unstructured":"Wyatt JK, Dijk DJ, Ritz-de Cecco A, Ronda JM, Czeisler CA (2006) Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent. Sleep 29:609\u2013618","journal-title":"Sleep"},{"key":"3530_CR50","doi-asserted-by":"crossref","unstructured":"Xu XH, Qiu MH, Dong H, Qu WM, Urade Y, Huang ZL (2014) GABA transporter-1 inhibitor NO-711 alters the EEG power spectra and enhances non-rapid eye movement sleep during the active phase in mice. Eur Neuropsychopharmacol 24:585\u2013594","DOI":"10.1016\/j.euroneuro.2013.09.002"},{"key":"3530_CR51","first-page":"A220","volume":"33","author":"O Yalkinoglu","year":"2010","unstructured":"Yalkinoglu O, Zisapel N, Nir T, Piechatzek R, Schorr-Neufing U, Bitterlich N, Allgaier C, Oertel R, Kluge A, Laudon M (2010) Phase-I study of the safety, tolerability, pharmacokinetics and sleep promoting activity of Neu-P11, a novel putative insomnia drug in healthy humans. Sleep 33:A220","journal-title":"Sleep"},{"key":"3530_CR52","first-page":"5","volume":"36","author":"CX Yu","year":"2001","unstructured":"Yu CX, Wu GC, Xu SF, Chen CH (2001) Effect of melatonin on release of beta-endorphin, norepinephrine and 5-hydroxytryptamine in rat brain. Yao Xue Xue Bao 36:5\u20139","journal-title":"Yao Xue Xue Bao"},{"key":"3530_CR53","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.neuropharm.2011.08.050","volume":"62","author":"X Zhao","year":"2012","unstructured":"Zhao X, Xu Y, Zhao Q, Chen CR, Liu AM, Huang ZL (2012) Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: descending monoamine system and opioid receptors are differentially involved. Neuropharmacology 62:843\u2013854","journal-title":"Neuropharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3530-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-014-3530-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3530-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T05:17:49Z","timestamp":1565327869000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-014-3530-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,4]]},"references-count":53,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["3530"],"URL":"https:\/\/doi.org\/10.1007\/s00213-014-3530-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,4]]}}}